Advanced
  Home Compare Reports

Comparison with Similar Reports

Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disea...

Publisher:        MarketsandMarkets

# of Pages:        325

Rating: 

1 User License $4,950

Publication Date:  November, 2021

Price:       $4,950 / User License




1 INTRODUCTION 51
1.1 OBJECTIVES OF THE STUDY 51
1.2 MARKET DEFINITION 51
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 51
1.3 MARKET SCOPE 52
1.3.1 MARKETS COVERED 52
FIGURE 1 ANATOMIC PATHOLOGY MARKET SEGMENTATION 52
1.3.2 YEARS CONSIDERED FOR THE STUDY 53
1.4 CURRENCY 53
1.5 STAKEHOLDERS 53
1.6 SUMMARY OF CHANGES 54
2 RESEARCH METHODOLOGY 55
2.1 RESEARCH DATA 55
FIGURE 2 RESEARCH DESIGN 55
2.1.1 SECONDARY DATA 56
2.1.1.1 Secondary sources 57
2.1.2 PRIMARY DATA 57
2.1.2.1 Key data from primary sources 58
2.1.2.2 Key industry insights 59
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (ANATOMIC PATHOLOGY MARKET) 59
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 60
2.2 MARKET SIZE ESTIMATION 60
2.2.1 APPROACH 1: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 60
2.2.1.1 Bottom-up approach for the instruments and consumables market 61
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 61
2.2.2 APPROACH 2: SECONDARY DATA & PRIMARY INTERVIEWS 61
2.2.3 APPROACH 3: TOP-DOWN APPROACH 61
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 62
2.2.3.1 Services market estimation based on the number of tests 62
2.2.3.2 Services market estimation based on procedures 63
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS IN THE ANATOMIC PATHOLOGY MARKET
(2021–2026) 64
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 64
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 65
FIGURE 9 DATA TRIANGULATION METHODOLOGY 65
2.4 MARKET SHARE ANALYSIS 66
2.5 ASSUMPTIONS FOR THE STUDY 66
2.6 RISK ASSESSMENT 67
TABLE 1 RISK ASSESSMENT: ANATOMIC PATHOLOGY MARKET 67
2.6.1 COVID-19 SPECIFIC ASSUMPTIONS 67
2.7 LIMITATIONS 68
2.7.1 METHODOLOGY-RELATED LIMITATIONS 68
2.7.2 SCOPE-RELATED LIMITATIONS 68
2.8 GROWTH RATE ASSUMPTIONS 68
2.9 COVID-19 ECONOMIC ASSESSMENT 68
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 69
FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 70
3 EXECUTIVE SUMMARY 71
FIGURE 12 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 71
FIGURE 13 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 72
FIGURE 14 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 72
FIGURE 15 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 73
FIGURE 16 ANATOMIC PATHOLOGY MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 73
FIGURE 17 ANATOMIC PATHOLOGY MARKET: REGIONAL SNAPSHOT 74
4 PREMIUM INSIGHTS 75
4.1 ANATOMIC PATHOLOGY MARKET OVERVIEW 75
FIGURE 18 HIGH INCIDENCE OF CANCER TO DRIVE MARKET GROWTH 75
4.2 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE 76
FIGURE 19 SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE
NORTH AMERICAN ANATOMIC PATHOLOGY MARKET 76
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET 77
FIGURE 20 COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 77
5 MARKET OVERVIEW 78
5.1 INTRODUCTION 78
5.2 MARKET DYNAMICS 78
FIGURE 21 ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS 78
5.2.1 DRIVERS 79
5.2.1.1 High incidence of cancer and other target diseases 79
TABLE 2 INCREASING INCIDENCE OF CANCER, BY REGION,
2020 VS. 2030 VS. 2040 (MILLION) 79
TABLE 3 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS,
2015 VS. 2018 VS. 2035 79
5.2.1.2 Recommendations for cancer screening 80
5.2.1.3 Availability of reimbursement 80
5.2.1.4 Growing focus on personalized medicine 81
TABLE 4 % OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2014 TO 2020 81
5.2.2 OPPORTUNITIES 82
5.2.2.1 Increasing number of clinical trials pertaining to cancer drugs 82
5.2.2.2 Emerging markets offer lucrative opportunities 82
5.2.2.3 Companion diagnostics 83
5.2.3 CHALLENGES 83
5.2.3.1 Availability of refurbished products 83
5.2.3.2 Lack of skilled professionals 84
TABLE 5 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018 84
5.2.3.3 Product failures and recalls 84
5.2.3.4 Inadequate infrastructure and low awareness in middle- and low-income countries 84
5.2.4 TRENDS 85
5.2.4.1 Reagent rental agreements 85
5.2.5 IMPACT OF COVID-19 ON THE ANATOMIC PATHOLOGY MARKET 85
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 86
5.4 RANGES/SCENARIOS 87
5.4.1 ANATOMIC PATHOLOGY MARKET 87
FIGURE 22 PESSIMISTIC SCENARIO 87
FIGURE 23 OPTIMISTIC SCENARIO 87
FIGURE 24 REALISTIC SCENARIO 88
5.5 PRICING ANALYSIS 88
TABLE 6 PRICES OF ANATOMIC PATHOLOGY PRODUCTS 88
5.6 VALUE CHAIN ANALYSIS 89
FIGURE 25 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES 89
5.7 SUPPLY CHAIN ANALYSIS 90
FIGURE 26 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 90
5.8 ECOSYSTEM ANALYSIS 91
5.8.1 ROLE IN THE ECOSYSTEM 91
FIGURE 27 KEY PLAYERS IN THE ANATOMIC PATHOLOGY ECOSYSTEM 92
5.9 TECHNOLOGY ANALYSIS 92
TABLE 7 TECHNOLOGICAL ADVANCEMENT IN THE ANATOMIC PATHOLOGY MARKET (2018–2021) 92
5.10 REGULATORY LANDSCAPE 93
FIGURE 28 510(K) APPROVAL PROCESS 93
5.11 PATENT ANALYSIS 94
5.12 TRADE ANALYSIS 95
5.12.1 TRADE ANALYSIS FOR TISSUE PROCESSING SYSTEMS 95
TABLE 8 IMPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 95
TABLE 9 EXPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION) 95
5.13 PORTER’S FIVE FORCES ANALYSIS 95
TABLE 10 PORTER’S FIVE FORCES ANALYSIS (2020): ANATOMIC PATHOLOGY MARKET 96
5.13.1 THREAT OF NEW ENTRANTS 96
5.13.2 INTENSITY OF COMPETITIVE RIVALRY 96
5.13.3 BARGAINING POWER OF BUYERS 96
5.13.4 BARGAINING POWER OF SUPPLIERS 96
5.13.5 THREAT OF SUBSTITUTES 96
6 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE 97
6.1 INTRODUCTION 98
TABLE 11 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 98
TABLE 12 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 98
6.1.1 PRIMARY NOTES 98
6.1.1.1 Key industry insights 98
6.2 SERVICES 99
TABLE 13 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 99
TABLE 14 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 99
6.2.1 HISTOPATHOLOGY SERVICES 99
6.2.1.1 Rising incidence of cancer is a key factor driving market growth 99
FIGURE 29 STEPS IN HISTOPATHOLOGY SLIDE PREPARATION 99
TABLE 15 HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 100
TABLE 16 HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 100
6.2.2 CYTOPATHOLOGY SERVICES 100
6.2.2.1 Government focus on cervical cancer screening has boosted the growth of the cytopathology services market 100
TABLE 17 CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 101
TABLE 18 CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 101
6.3 CONSUMABLES 102
TABLE 19 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 102
TABLE 20 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 102
6.3.1 ANTIBODIES 102
TABLE 21 ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 103
TABLE 22 ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 103
6.3.1.1 Primary antibodies 103
6.3.1.1.1 High specificity and accuracy of primary antibodies to drive the market 103
TABLE 23 PRIMARY ANTIBODIES MARKET, BY REGION, 2016–2020 (USD MILLION) 104
TABLE 24 PRIMARY ANTIBODIES MARKET, BY REGION, 2021–2026 (USD MILLION) 104
6.3.1.2 Secondary antibodies 104
6.3.1.2.1 Versatility of secondary antibodies ensuring their stable demand among end users 104
TABLE 25 SECONDARY ANTIBODIES MARKET, BY REGION, 2016–2020 (USD MILLION) 105
TABLE 26 SECONDARY ANTIBODIES MARKET, BY REGION, 2021–2026 (USD MILLION) 105
6.3.2 KITS & REAGENTS 105
TABLE 27 KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 106
TABLE 28 KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 106
6.3.2.1 Stains & solvents 106
6.3.2.1.1 Introduction of automation can limit the market growth 106
TABLE 29 STAINS & SOLVENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 107
TABLE 30 STAINS & SOLVENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 107
6.3.2.2 Fixatives 107
6.3.2.2.1 Adoption of non-toxic fixatives to drive market growth 107
TABLE 31 FIXATIVES MARKET, BY REGION, 2016–2020 (USD MILLION) 108
TABLE 32 FIXATIVES MARKET, BY REGION, 2021–2026 (USD MILLION) 108
6.3.2.3 Other kits & reagents 108
TABLE 33 OTHER KITS & REAGENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 109
TABLE 34 OTHER KITS & REAGENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 109
6.3.3 PROBES 109
6.3.3.1 Increasing research to aid the market growth 109
TABLE 35 PROBES MARKET, BY REGION, 2016–2020 (USD MILLION) 110
TABLE 36 PROBES MARKET, BY REGION, 2021–2026 (USD MILLION) 110
6.3.4 OTHER CONSUMABLES 110
TABLE 37 OTHER CONSUMABLES MARKET, BY REGION, 2016–2020 (USD MILLION) 111
TABLE 38 OTHER CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION) 111
6.4 INSTRUMENTS 111
TABLE 39 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 112
TABLE 40 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 112
6.4.1 SLIDE STAINING SYSTEMS 112
6.4.1.1 Availability of automated systems will drive market growth during the forecast period 112
TABLE 41 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2016–2020 (USD MILLION) 113
TABLE 42 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION) 113
6.4.2 TISSUE PROCESSING SYSTEMS 114
6.4.2.1 Rising adoption of automation is a key trend in the tissue processing systems market 114
TABLE 43 TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2016–2020 (USD MILLION) 114
TABLE 44 TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION) 114
6.4.3 CELL PROCESSORS 115
6.4.3.1 Cell processors are used to remove unwanted matter in samples—making them important instruments in the market 115
TABLE 45 CELL PROCESSORS MARKET, BY REGION, 2016–2020 (USD MILLION) 115
TABLE 46 CELL PROCESSORS MARKET, BY REGION, 2021–2026 (USD MILLION) 115
6.4.4 MICROTOMES 116
6.4.4.1 Rotary microtomes are the most commonly used microtomes 116
TABLE 47 MICROTOMES MARKET, BY REGION, 2016–2020 (USD MILLION) 116
TABLE 48 MICROTOMES MARKET, BY REGION, 2021–2026 (USD MILLION) 116
6.4.5 EMBEDDING SYSTEMS 117
6.4.5.1 Liquid paraffin is the most commonly used embedding medium 117
TABLE 49 EMBEDDING SYSTEMS MARKET, BY REGION, 2016–2020 (USD MILLION) 117
TABLE 50 EMBEDDING SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION) 117
6.4.6 COVERSLIPPERS 118
6.4.6.1 Coverslippers are widely used instruments in research 118
TABLE 51 COVERSLIPPERS MARKET, BY REGION, 2016–2020 (USD MILLION) 118
TABLE 52 COVERSLIPPERS MARKET, BY REGION, 2021–2026 (USD MILLION) 118
6.4.7 OTHER INSTRUMENTS 119
TABLE 53 OTHER INSTRUMENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 119
TABLE 54 OTHER INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 119
7 ANATOMIC PATHOLOGY MARKET, BY APPLICATION 120
7.1 INTRODUCTION 121
7.1.1 PRIMARY NOTES 121
7.1.1.1 Key industry insights 121
TABLE 55 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 121
TABLE 56 ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 121
7.2 DISEASE DIAGNOSTICS 122
TABLE 57 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2016–2020 (USD MILLION) 122
TABLE 58 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2021–2026 (USD MILLION) 122
7.2.1 CANCER 122
TABLE 59 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 123
TABLE 60 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 123
7.2.1.1 Breast cancer 123
7.2.1.1.1 Breast cancer accounts for the highest mortality rate among cancers in North America 123
TABLE 61 BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040 124
TABLE 62 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2016–2020 (USD MILLION) 124
TABLE 63 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2021–2026 (USD MILLION) 124
7.2.1.2 Gastrointestinal cancer 125
7.2.1.2.1 The rising incidence of gastric cancer will boost the market growth 125
TABLE 64 COLORECTAL CANCER INCIDENCE, BY REGION, 2020 VS. 2040 125
TABLE 65 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2016–2020 (USD MILLION) 125
TABLE 66 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2021–2026 (USD MILLION) 126
7.2.1.3 Lung cancer 126
7.2.1.3.1 Lung cancer is the most common cancer in the world 126
TABLE 67 LUNG CANCER INCIDENCE, BY REGION, 2020 VS. 2040 126
TABLE 68 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2016–2020 (USD MILLION) 127
TABLE 69 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2021–2026 (USD MILLION) 127
7.2.1.4 Prostate cancer 127
7.2.1.4.1 Prostate cancers are prevalent in the geriatric male population 127
TABLE 70 PROSTATE CANCER INCIDENCE, BY REGION, 2020 VS. 2040 128
TABLE 71 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2016–2020 (USD MILLION) 128
TABLE 72 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2026 (USD MILLION) 128
7.2.1.5 Other cancers 129
TABLE 73 MELANOMA INCIDENCE, BY REGION, 2020 VS. 2040 129
TABLE 74 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION,
2016–2020 (USD MILLION) 129
TABLE 75 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION,
2021–2026 (USD MILLION) 130
7.2.2 OTHER DISEASES 130
TABLE 76 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2016–2020 (USD MILLION) 131
TABLE 77 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2021–2026 (USD MILLION) 131
7.3 MEDICAL RESEARCH 131
7.3.1 GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT 131
TABLE 78 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2016–2020 (USD MILLION) 132
TABLE 79 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2021–2026 (USD MILLION) 132
8 ANATOMIC PATHOLOGY MARKET, BY END USER 133
8.1 INTRODUCTION 134
8.1.1 PRIMARY NOTES 134
8.1.1.1 Key industry insights 134
TABLE 80 ANATOMIC PATHOLOGY MARKET, BY END USER, 2016–2020 (USD MILLION) 134
TABLE 81 ANATOMIC PATHOLOGY MARKET, BY END USER, 2021–2026 (USD MILLION) 134
8.2 HOSPITAL LABORATORIES 135
8.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 135
TABLE 82 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016–2020 (USD MILLION) 135
TABLE 83 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2021–2026 (USD MILLION) 136
8.3 CLINICAL LABORATORIES 136
8.3.1 INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT 136
TABLE 84 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016–2020 (USD MILLION) 137
TABLE 85 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021–2026 (USD MILLION) 137
8.4 OTHER END USERS 137
TABLE 86 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2016–2020 (USD MILLION) 138
TABLE 87 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2021–2026 (USD MILLION) 138
9 ANATOMIC PATHOLOGY MARKET, BY REGION 139
9.1 INTRODUCTION 140
TABLE 88 ANATOMIC PATHOLOGY MARKET, BY REGION, 2016–2020 (USD MILLION) 140
TABLE 89 ANATOMIC PATHOLOGY MARKET, BY REGION, 2021–2026 (USD MILLION) 140
9.2 NORTH AMERICA 141
FIGURE 30 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012–2035 141
FIGURE 31 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT 142
TABLE 90 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 142
TABLE 91 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 143
TABLE 92 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION) 143
TABLE 93 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION) 143
TABLE 94 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 144
TABLE 95 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 144
TABLE 96 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 144
TABLE 97 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 145
TABLE 98 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION) 145
TABLE 99 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION) 145
TABLE 100 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 101 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2021–2026 (USD MILLION) 146
TABLE 102 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 103 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 146
TABLE 104 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 147
TABLE 105 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 147
TABLE 106 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 147
TABLE 107 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 147
TABLE 108 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION) 148
TABLE 109 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 110 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 148
TABLE 111 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 149
9.2.1 US 149
9.2.1.1 The US dominates the global anatomic pathology market 149
TABLE 112 US: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 150
TABLE 113 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 150
TABLE 114 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 151
TABLE 115 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 151
TABLE 116 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 151
TABLE 117 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 152
TABLE 118 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 152
TABLE 119 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 153
TABLE 120 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 153
TABLE 121 US: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 122 US: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 154
TABLE 123 US: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 154
TABLE 124 US: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 154
TABLE 125 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 154
TABLE 126 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 155
TABLE 127 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 155
TABLE 128 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 155
TABLE 129 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 156
TABLE 130 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 156
TABLE 131 US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 156
TABLE 132 US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 157
9.2.2 CANADA 157
9.2.2.1 High burden of cancer to support market growth 157
TABLE 133 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 157
TABLE 134 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 158
TABLE 135 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 158
TABLE 136 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 158
TABLE 137 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 138 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 159
TABLE 139 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 159
TABLE 140 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 160
TABLE 141 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 160
TABLE 142 CANADA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 160
TABLE 143 CANADA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 161
TABLE 144 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 161
TABLE 145 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 161
TABLE 146 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 161
TABLE 147 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 162
TABLE 148 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 162
TABLE 149 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 162
TABLE 150 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 151 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 152 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 163
TABLE 153 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 164
9.3 EUROPE 164
FIGURE 32 EUROPE: CANCER INCIDENCE & MORTALITY, 2012–2035 165
TABLE 154 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 165
TABLE 155 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 166
TABLE 156 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 166
TABLE 157 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 166
TABLE 158 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 167
TABLE 159 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 167
TABLE 160 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 167
TABLE 161 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 162 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 163 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 164 EUROPE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 165 EUROPE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 166 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 167 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 168 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 170
TABLE 169 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 170
TABLE 170 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 170
TABLE 171 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 170
TABLE 172 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 171
TABLE 173 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 171
TABLE 174 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 171
TABLE 175 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 172
9.3.1 GERMANY 172
9.3.1.1 Availability of reimbursement for colorectal cancer screening to support market growth 172
TABLE 176 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 173
TABLE 177 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION) 173
TABLE 178 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION) 173
TABLE 179 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 180 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 174
TABLE 181 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 174
TABLE 182 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 174
TABLE 183 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 184 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION) 175
TABLE 185 GERMANY: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 186 GERMANY: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 187 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 176
TABLE 188 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 189 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 176
TABLE 190 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 177
TABLE 191 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 177
TABLE 192 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 177
TABLE 193 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 178
TABLE 194 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 178
TABLE 195 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 178
TABLE 196 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 179
9.3.2 FRANCE 179
9.3.2.1 Government funding for cancer diagnosis & prevention to support market growth 179
TABLE 197 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040 180
TABLE 198 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 180
TABLE 199 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 180
TABLE 200 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 180
TABLE 201 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 202 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 181
TABLE 203 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 204 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 182
TABLE 205 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 182
TABLE 206 FRANCE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 182
TABLE 207 FRANCE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 183
TABLE 208 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 183
TABLE 209 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 183
TABLE 210 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 183
TABLE 211 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 184
TABLE 212 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION) 184
TABLE 213 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION) 184
TABLE 214 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 185
TABLE 215 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 185
TABLE 216 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 185
TABLE 217 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 186
9.3.3 UK 186
9.3.3.1 Government initiatives to drive market growth in the UK 186
TABLE 218 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 187
TABLE 219 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 187
TABLE 220 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 187
TABLE 221 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
TABLE 222 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 188
TABLE 223 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 188
TABLE 224 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 189
TABLE 225 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 189
TABLE 226 UK: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 227 UK: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 228 UK: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 190
TABLE 229 UK: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 230 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 190
TABLE 231 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 191
TABLE 232 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 191
TABLE 233 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 191
TABLE 234 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 192
TABLE 235 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 192
TABLE 236 UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 192
TABLE 237 UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 193
9.3.4 ITALY 193
9.3.4.1 Growing geriatric population to support market growth in Italy 193
TABLE 238 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 194
TABLE 239 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION) 194
TABLE 240 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION) 194
TABLE 241 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 195
TABLE 242 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 195
TABLE 243 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 195
TABLE 244 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 196
TABLE 245 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION) 196
TABLE 246 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION) 196
TABLE 247 ITALY: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION) 197
TABLE 248 ITALY: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION) 197
TABLE 249 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 197
TABLE 250 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 197
TABLE 251 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION) 198
TABLE 252 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION) 198
TABLE 253 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION) 198
TABLE 254 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION) 198
TABLE 255 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION) 199
TABLE 256 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION) 199
TABLE 257 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION) 199
TABLE 258 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION) 200

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127